NCT03129347View on ClinicalTrials.gov

Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

June 9, 2017

Study Completion Date

July 3, 2017

Conditions
Opioid-Related Disorders
Interventions
DRUG

Nalmefene

Comparing pharmacokinetics of intranasal nalmefene to intramuscular nalmefene

Trial Locations (1)

66212

Vince and Associates Clinical Research, Overland Park

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT03129347 - Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers | Biotech Hunter | Biotech Hunter